Sangamo Biosciences (SGMO) Misses Q3 EPS by 2c

October 26, 2016 4:05 PM EDT
Get Alerts SGMO Hot Sheet
Trade SGMO Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Sangamo Biosciences (NASDAQ: SGMO) reported Q3 EPS of ($0.27), $0.02 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $4.24 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment